MedicarePartD.guide

A non-government resource built from CMS public data

HIV treatment and prevention on every 2026 North Carolina Part D plan

Pick a drug class, or type the drugs you want to check, and see which of the 12 stand-alone Part D plans in North Carolina cover each one, on what tier, and with what restrictions.

A class overrides typed names. Separate names with commas; brand or generic both work.

  • Covered
  • Covered, needs prior authorization (PA) or step therapy (ST)
  • Not on the formulary
  • QL 60/30d = quantity limit, 60 units per 30 days

12 plans, cheapest premium first. Scroll sideways for all of them →

HIV treatment and prevention by 2026 North Carolina Part D plan
DrugWellcare Value Script$3.60/moS4802-143Wellcare Classic$4.70/moS4802-081Humana Basic Rx Plan$6.80/moS5884-133Humana Value Rx Plan$32.00/moS5884-187AARP Medicare Rx Saver from UHC$56.90/moS5921-353HealthSpring Extra Rx$78.00/moS5617-358Blue Medicare Rx Standard$83.90/moS5540-002SilverScript Choice$90.20/moS5601-016HealthSpring Assurance Rx$110.40/moS5617-217Humana Premier Rx Plan$110.90/moS5884-154AARP Medicare Rx Preferred from UHC$119.80/moS5921-390Blue Medicare Rx Enhanced$163.20/moS5540-004
Biktarvybictegravir/emtricitabine/tenofovir alafenamideTier 525%Tier 525%Tier 525%QL 30/30dTier 526%QL 30/30dTier 525%QL 30/30dTier 525%Tier 525%QL 30/30dTier 525%Tier 525%Tier 533%QL 30/30dTier 531%QL 30/30dTier 533%QL 30/30d
Dovatodolutegravir and lamivudineTier 525%Tier 525%Tier 525%QL 30/30dTier 526%QL 30/30dTier 525%QL 30/30dTier 525%Tier 525%QL 30/30dTier 525%Tier 525%Tier 533%QL 30/30dTier 531%QL 30/30dTier 533%QL 30/30d
Triumeqabacavir/dolutegravir/lamivudineTier 440%Tier 427%Tier 432%QL 180/30dTier 434%QL 180/30dTier 434%QL 180/30dTier 431%QL 300/30dTier 432%QL 180/30dTier 433%Tier 432%QL 300/30dTier 450%QL 180/30dTier 433%QL 180/30dTier 440%QL 180/30d
Genvoyaelvitegravir/cobicistat/emtricitabine/tenofovir alafenamideTier 525%Tier 525%Tier 525%QL 30/30dTier 526%QL 30/30dTier 525%QL 30/30dTier 525%QL 30/30dTier 525%QL 30/30dTier 525%Tier 525%QL 30/30dTier 533%QL 30/30dTier 531%QL 30/30dTier 533%QL 30/30d
Odefseyemtricitabine/rilpivirine/tenofovir alafenamideTier 525%Tier 525%Tier 525%QL 30/30dTier 526%QL 30/30dTier 525%QL 30/30dTier 525%QL 30/30dTier 525%QL 30/30dTier 525%Tier 525%QL 30/30dTier 533%QL 30/30dTier 531%QL 30/30dTier 533%QL 30/30d
Symtuzadarunavir/cobicistat/emtricitabine/tenofovir alafenamideTier 525%Tier 525%Tier 525%QL 30/30dTier 526%QL 30/30dTier 525%QL 30/30dTier 525%Tier 525%QL 30/30dTier 525%Tier 525%Tier 533%QL 30/30dTier 531%QL 30/30dTier 533%QL 30/30d
Julucadolutegravir and rilpivirineTier 525%Tier 525%Tier 525%QL 30/30dTier 526%QL 30/30dTier 525%QL 30/30dTier 525%Tier 525%QL 30/30dTier 525%Tier 525%Tier 533%QL 30/30dTier 531%QL 30/30dTier 533%QL 30/30d
Descovyemtricitabine and tenofovir alafenamideTier 525%QL 30/30dTier 525%QL 30/30dTier 525%QL 30/30dTier 526%QL 30/30dTier 525%QL 30/30dTier 525%QL 30/30dTier 525%QL 30/30dTier 525%Tier 525%QL 30/30dTier 533%QL 30/30dTier 531%QL 30/30dTier 533%QL 30/30d
Truvadaemtricitabine and tenofovir disoproxilNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
emtricitabine-tenofovirgeneric TruvadaTier 440%QL 30/30dTier 427%QL 30/30dTier 432%QL 30/30dTier 434%QL 30/30dTier 434%QL 30/30dTier 431%QL 30/30dTier 432%QL 30/30dTier 433%QL 30/30dTier 432%QL 30/30dTier 450%QL 30/30dTier 433%QL 30/30dTier 440%QL 30/30d
TivicaydolutegravirTier 525%Tier 525%Tier 525%QL 60/30dTier 526%QL 60/30dTier 525%QL 60/30dTier 431%QL 180/30dTier 525%QL 60/30dTier 525%Tier 432%QL 180/30dTier 533%QL 60/30dTier 531%QL 60/30dTier 533%QL 60/30d

Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.